To assess the β-catenin activation in human HCC tumors displaying all CTNNB1 mutations, we examined any co-expression of surrogate Wnt target genes such as Axin2, Regucalcin, Lect2 and GS using qRT-PCR. This evidence concerns the gene AXIN2 and hepatocellular carcinoma.